Inflammatory signaling in NAFLD is associated with activation of NF-κB by saturated fatty acids that activate sterol regulatory element-binding protein-1 (SREBP-1), which then leads to increased lipogenesis via acetyl-CoA carboxylase (88, 89). Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.